Real-time metabolic heat-based specific growth rate soft sensor for monitoring and control of high molecular weight hyaluronic acid production by Streptococcus zooepidemicus

Mohan, Naresh; Pavan, Satya Sai; Jayakumar, Anjali; Rathinavelu, Sivakumar; Sivaprakasam, Senthilkumar

doi:10.1007/s00253-022-11760-1

Cited by 7 publications

(1 citation statement)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…HA of high molecular weight (around 2.94 MDa) was extracted from Streptococcus zooepidemicus and purified by gel permeation chromatography as described in the literature. [ 11 ] To fabricate the cross‐linked HA polymer, the linker molecule (pyridine‐2,6‐diylbis(methylene))bis((2‐aminoethyl)(methyl)sulfonium) (Compound B) was synthesized from 2,6‐bis(bromomethyl)pyridine. Condensation of tert ‐butyl (2‐(methylthio)ethyl)carbamate with 2,6‐bis(bromomethyl)pyridine resulted in the desired (pyridine‐2,6‐diylbis(methylene))bis((2‐aminoethyl)(methyl)sulfonium).…”

Section: Resultsmentioning

confidence: 99%

Sulfonium‐Cross‐Linked Hyaluronic Acid‐Based Self‐Healing Hydrogel: Stimuli‐Responsive Drug Carrier with Inherent Antibacterial Activity to Counteract Antibiotic‐Resistant Bacteria

Patel,

Goswami,

Hazarika

et al. 2023

Adv Healthcare Materials

Self Cite

View full text Add to dashboard Cite

Augmentation of the activity of Food and Drug Administration‐approved antibiotics by an adjuvant or antibiotic carrier is considered one of the promising strategies to fight against antibiotic‐resistant bacteria. This study reports the development of sulfonium‐cross‐linked hyaluronic acid (HA)‐based polymer (HA‐SS‐HA) as an inherent antimicrobial agent and antibiotic carrier. The HA‐SS‐HA polymer offers the potential for encapsulating various classes of antibiotics and accomplishing a stimuli‐responsive release profile in the presence of hyaluronidase produced by bacterial cells within their extracellular environment. Systematic antibacterial studies reveal that the HA‐SS‐HA‐encapsulated antibiotics (vancomycin, amoxicillin, and tetracycline) restore its activity against the antibiotic‐resistant bacterial cells methicillin‐resistant Staphylococcus aureus (MRSA) and vancomycin‐resistant Enterococci (VRE), and Pseudomonas aeruginosa. The HA‐SS‐HA gel shows robust efficacy in eradicating the mature biofilm of Staphylococcus aureus (S. aureus). The membrane‐disrupting activity reveals that HA‐SS‐HA can also counteract the antibiotic resistance mechanism of the bacterial cells. The in vivo studies reveal excellent wound‐healing activity of HA‐SS‐HA in albino laboratory‐bred (BALB/c) mice. The outcome of additional antibacterial studies reveals that antibiotics‐encapsulated HA‐SS‐HA hydrogel can effectively combat Gram‐negative, Gram‐positive, and antibiotic‐resistant bacterial strains. Therefore, revitalizing the activity of commercial antibiotics by HA‐SS‐HA can be considered a valuable and economically effective strategy to fight against antibiotic‐resistant bacteria.

show abstract

Section: Resultsmentioning

confidence: 99%